EV Biologics (EV Biologics) Price-to-Tangible-Book : 0.03 (As of May. 21, 2024)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Price-to-Tangible-Book?

As of today (2024-05-21), EV Biologics's share price is $0.5541. EV Biologics's Tangible Book per Share of Dec. 2017 for the quarter that ended in Dec. 2017 was $16.79. Hence, EV Biologics's Price to Tangible Book Ratio of today is 0.03.

The historical rank and industry rank for EV Biologics's Price-to-Tangible-Book or its related term are showing as below:

YECO's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.78
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, EV Biologics's share price is $0.5541. EV Biologics's Book Value per Sharefor the quarter that ended in Dec. 2017 was $17.52. Hence, EV Biologics's P/B Ratio of today is 0.03.

EV Biologics Price-to-Tangible-Book Historical Data

The historical data trend for EV Biologics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Price-to-Tangible-Book Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Price-to-Tangible-Book

1.15

2.26

3.70

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Price-to-Tangible-Book	Get a 7-Day Free Trial												2.26	4.37	2.65	3.70	0.16

Competitive Comparison of EV Biologics's Price-to-Tangible-Book

For the Biotechnology subindustry, EV Biologics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EV Biologics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, EV Biologics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where EV Biologics's Price-to-Tangible-Book falls into.

EV Biologics Price-to-Tangible-Book Calculation

EV Biologics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2017 )
	=	0.5541	/	16.792
	=	0.03

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

EV Biologics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of EV Biologics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Price-to-Tangible-Book

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3